Notice of Intent for Monoclonal Antibodies and Plasmids Services for Malaria
SAM.GOV Due: May 13, 2025 at 06:00 PM UTC
In-Active Special Notice Source Url

Summary

The National Institute of Allergy and Infectious Diseases (NIAID) is issuing a Notice of Intent to negotiate a sole source contract with Genscript USA, Inc. for the provision of monoclonal antibodies and plasmid services specifically aimed at advancing research in malaria vaccine development. This opportunity is not a request for proposals but rather a continuation of an existing project that requires custom gene to antibody services, including the preparation of plasmid heavy and light chains. Contractors with expertise in immunogenetics and the ability to provide these specialized services are encouraged to submit capability statements, as continuity in service is critical for maintaining the integrity of research results. The work will be performed in Rockville, MD, and interested parties must register with the NIAID electronic Simplified Acquisition Submission System (eSASS) to participate.
Description

PRE-SOLICITATION NOTICE

NOI-NIAID-25-2260389

NAICS – 541380

This is a Notice of Intent, not a request for proposal.  The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes

Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
541380
Set Aside
None
Place of Performance
Piscataway , New Jersey 08854
Point of Contact
Full Name Email Phone Type
Leah Hinson [email protected] primary
Attachments
  • 2_2260389_NOI.pdf